EMDF (EMDF) Stock Price & Analysis
EMDF (EMDF) rose 0.00% to USD 0 as of July 26, 2026 at 00:04 UTC, according to Nexqual real-time market data.
EMDF last closed at USD 0; the session ranged USD 0–0 on volume of 8,960 shares. Market capitalization is $144,706, with a 52-week range of USD 0–0.01 (OID). Source: Nexqual, July 26, 2026 at 00:04 UTC.
Key Statistics (as of July 26, 2026 at 00:04 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 8,960 shares |
| Market Cap | $144,706 |
| Exchange | OID |
Technical Analysis (EMDF)
Nexqual's technical model rates EMDF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 00:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (EMDF)
Wall Street analysts rate EMDF "None", per Nexqual as of July 26, 2026 at 00:04 UTC.
| Consensus Rating | None |
|---|
Earnings (EMDF)
Source: Nexqual, July 26, 2026 at 00:04 UTC.
Financials & Fundamentals (EMDF)
| Total Revenue | $84,755 |
|---|---|
| Revenue Growth (YoY) | +19092.50% |
| Gross Margin | +54.20% |
| Operating Margin | -113.53% |
| Profit Margin | -247.26% |
| Current Ratio | 0.09 |
| Total Cash | $30,418 |
| Total Debt | $788,960 |
| Free Cash Flow | $41,614 |
Source: Nexqual, July 26, 2026 at 00:04 UTC.
Financial Health Score (EMDF)
Nexqual rates EMDF's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 00:04 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $30K cash, no debt |
| Cash Flow | Strong — FCF $42K, 49% margin |
| Efficiency | Mixed — No data |
Ownership (EMDF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.02% |
| Shares Outstanding | 42.56M |
Source: Nexqual, July 26, 2026 at 00:04 UTC.
Leadership (EMDF)
EMDF is led by Gary G. Kompothecras (age 65), CEO, President & Director, per Nexqual as of July 26, 2026 at 00:04 UTC.
| CEO, President & Director | Gary G. Kompothecras (age 65) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ENHT | ENHERENT CORP | USD 0 | ▲ 0% |
| EKCS | Electronic Control Security, In | USD 0 | ▲ 0% |
| UNVC | UNIVEC, Inc. | USD 0 | ▲ 33.33% |
| EMBR | Embarr Downs, Inc. | USD 0 | ▲ 0% |
| ADLI | AMERICAN MEDICAL TECHNOLOGIES | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 00:04 UTC. This page is informational and not investment advice.